Announcement PDF AMAERO LTD (ASX: 3DA | OTC: AMROF) Investor Presentation A leading U.S. domestic producer of high-value refractory and titanium alloy spherical powders & manufacturer of near-net- shape parts for mission-critical components across defense, space, aviation, medical and industrials 24 October 2025 (ASX: 3DA | OTC: AMROF) Important Notice and Disclaimer This presentation has been prepared by Amaero Ltd (ACN 633 541 634) (“Amaero” or the “Company”) and does not constitute or form part of, and should not be construed as, an offer, solicitation or invitation to subscribe for, underwrite or otherwise acquire, any securities of Amaero or any member of its group nor should it or any part of it form the basis of, or be relied on in connection with, any contract to purchase or subscribe for any securities of Amaero or any member of its group, nor shall it or any part of it form the basis of or be relied on in connection with any contract or commitment whatsoever. This presentation is not a prospectus, product disclosure statement or other disclosure document under Australian law (or any other law) and has not been lodged with the Australian Securities and Investments Commission (or any other regulatory body in Australia or abroad). This presentation is being provided to you on the basis that you are, and you represent and warrant that you are, a person to whom the provision of the information in this presentation is permitted by laws of the jurisdiction in which you are situated without the need for registration, lodgement or approval of a formal disclosure document or any other filing or formality in accordance with the laws of that foreign jurisdiction. If you are not such a person, you are not entitled to read or attend this presentation and must notify Amaero immediately and promptly return this presentation to Amaero and destroy all copies, whether held in electronic or printed form or otherwise, without retaining any copies. This presentation contains summary information about Amaero and its activities, which is current as at the date of this presentation. The information included in this presentation is of a general nature and does not purport to be complete nor does it contain all the information which a prospective investor should consider when making an investment decision. Each recipient of this presentation should make its own enquiries and investigations regarding all information in this presentation including but not limited to the assumptions, uncertainties and contingencies which may affect future operations of Amaero and the impact that different future outcomes may have on Amaero. This presentation has been prepared without taking account of any person’s investment objectives, financial situation or particular needs. Before making an investment decision, prospective investors should consider the appropriateness of the information having regard to their own objectives, financial situation and needs, make their own assessment of the information and seek legal, financial, accounting and taxation advice appropriate to their jurisdiction in relation to the information and any action taken on the basis of the information. The information included in this presentation has been provided to you solely for your information and background and is subject to updating, completion, revision and amendment and such information may change materially. Unless required by applicable law or regulation, no person (including Amaero) is under any obligation to update or keep current the information contained in this presentation and any opinions expressed in relation thereto are subject to change without notice. No representation or warranty, express or implied, is made as to the fairness, currency, accuracy, reasonableness or completeness of the information contained herein. Neither Amaero nor any other person accepts any liability and Amaero, its related bodies corporate and their respective directors, officers and employees, to the maximum extent permitted by law, expressly disclaim all liabilities for any loss howsoever arising, directly or indirectly, from this presentation or its contents. Recipients of this presentation should be aware that certain financial data included in the presentation may be considered "non-GAAP financial measures" within the meaning of Regulation G of the U.S. Securities Exchange Act of 1934. These non-GAAP financial measures, including EBITDA and EBITDA margin, do not have a standardized meaning prescribed by Australian Accounting Standards or International Financial Reporting Standards and therefore may not be comparable to similarly titled measures presented by other entities, nor should they be construed as an alternative to other financial measures determined in accordance with Australian Accounting Standards or International Financial Reporting Standards. Although Amaero believes these non-GAAP financial measures provide useful information to recipients in measuring the financial performance and condition of its business, recipients are cautioned not to place undue reliance on any such measures. Financial information contained in this presentation is unaudited, unless otherwise stated, and is therefore subject to change. Certain market and industry data (including industry forecasts, projections, market sizes, market shares and market positions) included in this presentation has been obtained from public filings, research, surveys or studies conducted by third parties, including industry and general publications, which has not been independently verified by Amaero, as well as from Amaero’s own internal estimates and research. Amaero cannot warrant or guarantee the adequacy, fairness, accuracy or completeness of such information. You should note that market data and statistics are inherently predictive and subject to uncertainty and not necessarily reflective of actual market conditions. There is no assurance that any of the industry or market forecasts, including management estimates, which are referred to in this presentation will be achieved. In addition, such data involves a number of assumptions and limitations, and there can be no guarantee as to the accuracy or reliability of such assumptions. In addition, while Amaero believes its own estimates and research are reliable, such estimates and research have not been verified by any independent source. This presentation includes forward-looking statements that reflect Amaero’s intentions, beliefs or current expectations concerning, among other things, Amaero’s results of operations, financial condition, liquidity, performance, prospects, growth, strategies and the industry in which Amaero operates. Such forward-looking statements may include financial projections which involve a significant element of subjective judgement, projection and analysis by Amaero’s management (that may or may not be correct) and estimates made by Amaero’s management that are based on uncertain events that may or may not occur. Such projections have not been endorsed, adopted or approved by Amaero’s Board of Directors as likely to be accurate (nor have they been adopted by the Board as a forecast). These forward-looking statements are subject to risks, uncertainties and assumptions and other factors, many of which are beyond the control of Amaero. Amaero cautions you that forward-looking statements are not guarantees of future performance and that its actual results of operations, financial condition, liquidity, performance, prospects, growth or opportunities and the development of the industry in which Amaero operates may differ materially from those made in or suggested by the forward-looking statements contained in this presentation. In addition, Amaero does not guarantee any particular rate of return or the performance of Amaero nor does it guarantee the repayment or maintenance of capital or any particular tax treatment. Investors should note that past performance may not be indicative of results or developments in future periods and cannot be relied upon as an indicator of (and provides no guidance as to) Amaero’s future performance. Amaero, its related bodies corporate and each of their respective directors, officers and employees expressly disclaim any obligation or undertaking to review, update or release any update of or revisions to any forward-looking statements in this presentation or any change in Amaero’s expectations or any change in events, conditions or circumstances on which these forward-looking statements are based, except as required by applicable law or regulation. This presentation and any materials distributed in connection with this presentation are not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would require any registration or licensing within such jurisdiction. The distribution of this presentation in certain jurisdictions may be restricted by law and persons into whose possession this presentation comes should inform themselves about and observe any such restrictions. (ASX: 3DA | OTC: AMROF) Financial Performance Select Financial Highlights Revenue Production Cash Used In Operations Cash and Restricted Cash Position EXIM Bank Loan  A$4.7 million (increased 445% vs Q1 FY25) – includes A$4.1 million powder and A$0.6 million PM-HIP  Increased 240% vs Q4 FY25  A$0.5M million order backlog from Q1 carried into Q2 FY26  A$9.9 million; includes A$4.7 inventory purchases for buffer stock to mitigate trade / tariff risk  A$50.9 at quarter-end1  US$5.7 million drawn post-quarter end on 3 Oct 2025  US$13.3 million outstanding (net of exposure fee) under the US$20.3 million facility (net of exposure fee) 1 1Includes A$2.5 million restricted cash balance (ASX: 3DA | OTC: AMROF) Scaling Manufacturing Production Manufacturing Optimization Consulting firm engaged to assess and evaluate process, safety, and quality controls to support scale-up Capacity Additional processing equipment ordered for commissioning in Q2 and Q3 FY2026 Powder Shipments 153% sequential increase from 4,900 kg in Q4 FY2025 to 12,410 kg in Q1 FY2026 Leadership Operations team restructured; Mark Struss appointed VP – Manufacturing Operations Atomization Output 240% increase from 8,000 kg in Q4 FY2025 to 27,000 kg in Q1 FY2026, driven by expansion from one 8-hour shift on a single atomizer to two 10-hour shifts operating six days per week on two atomizers 2 (ASX: 3DA | OTC: AMROF) Chairman and CEO re-locates to Chattanooga (ASX: 3DA | OTC: AMROF) Leadership Update: To facilitate the Company’s move into scaled production and commercialization, Chairman and CEO Hank Holland and his family relocated to Chattanooga, Tennessee during the quarter 3 (ASX: 3DA | OTC: AMROF) Material Qualification and Ongoing Improvements (ASX: 3DA | OTC: AMROF) Castheon / ADDMAN C103 Material Improvement Collaboration Completed Velo3D Qualification Condition Satisfied  Amaero and ADDMAN completed joint development to enhance C103 material properties, with testing confirming Amaero’s powder meets ADDMAN’s performance specifications and achieves wrought-like material properties.  As the Preferred Supplier of C103 powder, the companies will continue to collaborate to advance sovereign capabilities in propulsion and thermal protection systems for hypersonic and space applications.  Printing and testing of Amaero’s C103 and Ti64 powders by NCAME (Auburn University) confirmed conformance with industry standards, thereby satisfying Velo3D’s qualification condition1 4 1ASX Announcement “Technical Development Collaboration with Auburn University Velo3D Qualification Condition Satisfied for C103 and Ti64” dated 8 July 2025 (ASX: 3DA | OTC: AMROF) A$50 Million Placement (ASX: 3DA | OTC: AMROF) Capital Raising Use of Proceeds  Completed A$50 million Placement during the quarter1; SPP offered to eligible shareholders raised A$470,000 at the same issue price2  Funds will accelerate growth and unit cost-reduction initiatives previously scheduled for FY2027 and beyond1 5 1ASX Announcement “Amaero Secures A$50 Million to Accelerate Growth Initiatives” dated 21 August 2025 2ASX Announcement “Completion of Share Purchase Plan” dated 26 September 2025 (ASX: 3DA | OTC: AMROF) Key Leadership Hires 6 Brett Paduch – Chief Financial Officer Brings extensive audit, accounting and FP&A experience Mark Struss – VP - Manufacturing Operations Adds 25 years of aerospace, automotive, and industrial manufacturing expertise Dr. Arun Chattopadhyay – VP - Applied Research & Process Development Expanded responsibilities overseeing applied research and process optimization Dr. Jonathan Pegues – VP - Technology Development Formerly with Auburn NCAME and Castheon; leads material innovation and process advancement (ASX: 3DA | OTC: AMROF) Updated Financial Guidance  Amaero provided financial guidance for FY2026 revenue of A$30-35 million1 Revenue Outlook  Approximately 40% expected in 1H FY2026 and 60% in 2H FY20261 Revenue Phasing 7 (ASX: 3DA | OTC: AMROF) 1ASX Announcement “Updated Financial Guidance for FY2026” dated 3 September 2025 (ASX: 3DA | OTC: AMROF) Commercial Progress Titomic Exclusive Agreement  Entered into a five-year exclusive supplier and development agreement with Titomic Limited (ASX: TTT) for refractory and titanium alloy spherical powders. The collaboration combines Amaero’s scalable powder production with Titomic’s cold-spray manufacturing expertise for mission-critical aerospace and defense applications1  Received contracts from a U.S. Department of Defense Prime Contractor and have completed First Article parts production2  First Article acceptance marks a key milestone toward production part contracts and further validates PM-HIP manufacturing as a mature, scalable alternative to large casting and forgings2 Defense Prime Contractor Knust-Godwin Exclusive Agreement  Executed a five-year supply and strategic development agreement for titanium alloy powders with Knust-Godwin, a leading additive manufacturing and precision machining company operating a 240,000 sq ft facility near Houston, Texas Boeing Collaboration  Initiated a development collaboration with the Boeing Company, combining Amaero’s PM-HIP expertise in large near-net-shape parts with Boeing’s advanced manufacturing and materials capabilities to advance next-generation aerospace applications2 8 1ASX Announcement “Titomic Selects Amaero as Sole Supplier of Spherical Refractory and Titanium Powders” dated 1 September 2025 2Investor Presentation lodged with the ASX on 21 August 2025 (ASX: 3DA | OTC: AMROF) (ASX: 3DA) Advancing Commercial Opportunities 9  Development and production contracts supporting the U.S. Navy and Maritime Industrial Base  C103 powder opportunity in missile system  Tungsten powder opportunity for munitions  Zirconium powder opportunity for nuclear power  Refractory powder opportunity for cold spray application  Strategic supplier agreement with a large integrated additive manufacturer  Strategic supplier agreement with a medical device company  Investment tooling for semiconductor company  Production contracts for oil & gas company  Upcycling / recycling titanium coarse powder and stubs  Atomization and testing of development refractory alloy powders  Integration and/or co-location of adjacency manufacturing and processing capabilities (ASX: 3DA | OTC: AMROF) Representative Opportunities - (ASX: 3DA | OTC: AMROF) Amaero Headquarters 130 Innovation Drive McDonald, TN 37353 U.S.A. info@amaeroinc.com Investor Relations (United States) MZ Group Shannon Devine amaero@mzgroup.us (914) 352-5853 www.amaeroinc.com Investor Relations (Australia) Jane Morgan Management Jane Morgan jm@janemorganmanagement.com